Evaluate Sunosi ® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
Conditions:   Narcolepsy;   Obstructive Sleep Apnea;   Excessive Daytime Somnolence;   Excessive Sleepiness;   Postpartum Intervention:   Drug: Solriamfetol 150 mg Oral Tablet Sponsor:   Jazz Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2021 Category: Research Source Type: clinical trials